NQO1-DT and liver cancer: Although siRNA #4 and siRNA #5 both effectively knocked down the expression of FASRL, the knockdown effects of siFASRL#4 in the two liver cancer cell lines were inconsistent; thus, we chose siFASRL#1 and #5 instead of #4 for the subsequent experiments (Figure S8A,B, Supporting Information).